The Claim

Daily administration of GLP-1(9-36)amide at 25 nmol/kg for 14 days in obese diabetic ob/ob mice had no significant effect on fasting glucose, postprandial glucose, glucose tolerance, insulin sensitivity, insulin secretion, body weight, food intake, or pancreatic islet morphology.

Source: Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
16score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

In obese diabetic mice, a daily injection of GLP-1(9-36)amide at 25 nmol/kg for 14 days did not change fasting or after-meal blood sugar levels, glucose processing, insulin function, body weight, food intake, or pancreatic islet structure.

See the scientific wording

In obese diabetic ob/ob mice, daily administration of GLP-1(9-36)amide at 25 nmol/kg for 14 days showed no significant effect on fasting or postprandial glucose levels, glucose tolerance, insulin sensitivity, insulin secretion, body weight, food intake, or pancreatic islet morphology.

Why this might work

The broken-down form of GLP-1 does not trigger any change in how the body uses insulin or how much insulin the pancreas releases, so blood sugar stays the same even after two weeks of treatment.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.

    In diabetic mice, daily shots of a broken-down piece of GLP-1 didn’t change their blood sugar, insulin, weight, or pancreas over two weeks — just like the claim said.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.